Although our previous studies indicate that AR inhibition prevents hyperglycemia-induced NF-κB-dependent inflammatory signals, it is not known how AR inhibition increases the resistance of cells to withstand oxidative stress stimuli initiated by hyperglycemia. Here, NFKB1 is linked to Hyperglycemia.